Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exposed primary amine groups on self-proteins, primarily the ε-amino groups of lysine residues and the α-amino groups at the N-termini, are critical chemical sites for both physiological processes and pathological modifications (PubMed, PMID: 25611107). Biologically, these amines are involved in essential post-translational modifications, such as the formation of desmosine cross-links in elastin and collagen catalyzed by lysyl oxidase, which provide structural integrity to tissues (UniProt, P06737). In the context of disease, these groups are the primary targets for non-enzymatic glycation by reducing sugars, leading to the accumulation of advanced glycation end-products (AGEs) associated with diabetic complications and aging (NIH, StatPearls). Furthermore, these amines serve as the reactive sites for "haptens"—small molecules like penicillin or reactive drug metabolites—that covalently bind to self-proteins to form immunogenic complexes, potentially triggering severe hypersensitivity reactions or drug-induced autoimmunity (PubMed, PMID: 11526240). In biotechnology and medicine, these groups are intentionally targeted for the chemical fixation of bioprosthetic tissues using glutaraldehyde or for the site-specific conjugation of polymers and drugs to therapeutic proteins (PubMed, PMID: 10658700).
Covalent modification including acylation, alkylation, glycation, or cross-linking of primary amine groups (lysine side chains or N-termini) on endogenous proteins.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exposed primary amine groups on self-proteins.